HAI-ROBOTICS
24.3.2022 13:59:10 CET | Business Wire | Press release
HAI ROBOTICS will display its Autonomous Case-handling Robot (ACR) systems in Europe at the upcoming Transport and Logistics Innovation Week (SITL) 2022 in Paris from Apr. 5-8, an event it sees as the launchpad into more European countries.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220324005462/en/
SITL 2022 will also mark the debut of the company's local European team.
Considered a disruptive innovator, HAI ROBOTICS is committed to spearheading the future of warehouse automation, with a flexible, easily deployable and cost-effective solution that will massively increase supply chain efficiency in Europe.
Local Presence
Since setting up its regional headquarters in the Netherlands in late 2021, HAI ROBOTICS has expanded its presence quickly into several countries, such as France, Germany, Spain, Italy, the Benelux and the U.K.
It has quickly set up a local team, most of whom are industrial veterans.
Peter Guan, HAI ROBOTICS European General Manager, said HAI Robotics "is dedicated to hiring local top talent in each of the European key regions."
"The company has already employed the services of several native country managers with proven track records in the logistics automation industry. We keep searching for more local talent that can increase the level of our service and support," Mr Guan said.
"We are gearing up to do more exhibitions in Europe," he added.
An expert in building up, structuring and swiftly growing the European business of international companies that want to break into the market, Mr Guan used to be the sales & marketing director at Hikvision for more than ten years.
At SITL 2022, Mr Guan will be joined by Kai Ramadhin, VP of Sales & Marketing Europe, and Thierry Hennebiq, Country Manager France. Both were newly joined.
With more than 20 years of experience in the logistics market, Mr Ramadhin had previously worked with the Dutch corporation Van Riet Material Handling Systems as both interim CEO and the Director of Sales and Marketing.
With more than 10 years of experience in the intralogistics industry, Mr Hennebiq had previously fulfilled roles at the top system integrators in this industry including TGW, Dematic and Vanderlande.
The Better Fit
Compared with existing, especially traditional, warehouse automation solutions, HAI ROBOTICS believe its ACR systems are a better fit for European customers.
Take France, where SITL 2022 convenes, for example. Mr Hennebiq said "huge demand is observed," given the growing demand for logistic services.
"We think our ACR solution can give logistic service suppliers everything they need to optimize their warehouses for massively increased throughput and efficiency," he said.
Mr Ramadhin said HAI ROBOTICS' target industries include mainly 3PL, retail & e-commerce, fashion and FMCG. "Our ACR solution is catered to handle products in these markets."
Compared to logistic service suppliers employing a traditional human labor force, Mr Ramadhin said the ACR systems can "exponentially increase operational efficiency," whilst requiring less time to implement and being more cost-effective than traditional automation solutions.
"HAI ROBOTICS solution provides more flexibility in term of expansion ability, rapid deployment times and so on. So the sweet-spot of our solution is much more attractive," he said.
Mr Ramadhin noted the company is focused on creating a local network of system integrator, installation and service partners, so that any user of ACR systems can expect rapid and high-quality service wherever they are in Europe.
Since its foray into Europe last year, HAI ROBOTICS' presence has been expanding swiftly in the local warehousing logistics sector.
It has paired up with France-based global logistics solutions engineering company Savoye and has inked a strategic partnership with Greece's market leader in intralogistics Voyatzoglou Systems.
At a time when e-commerce booms, the company's ACR solution was deployed at a Micro-Fulfillment Center in Europe, significantly improving the last-mile delivery.
"We aim to provide our customers with high quality service and support, both through our own regional teams, as well as our robust network of installation and service partners," Mr Ramadhin said.
To see HAI ROBOTICS's ACR systems live, please visit booth K81, Paris - Nord Villepinte - Hall 6, during SITL 2022.
ABOUT HAI ROBOTICS
HAI ROBOTICS, the pioneer in Autonomous Case-handling Robot (ACR) systems, is committed to providing efficient, intelligent, flexible, and customized warehouse automation solutions through robotics technology and AI algorithms. It aims to create value for each factory and logistics warehouse. The HAIPICK ACR system, independently developed in 2015, is the world's first of its kind.
Founded in 2016 in Shenzhen, China, HAI ROBOTICS has offices in the U.S., Europe, Japan, Southeast Asia, Hong Kong and Taiwan, serving customers from more than 30 countries and regions.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220324005462/en/
Link:
Social Media:
https://www.facebook.com/HAIROBOTICS/videos/?ref=page_internal
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
NTT DOCOMO BUSINESS and Chile’s State-owned Copper Company CODELCO Launch a Study and Proof of Concept Aimed at Improving the Efficiency of Remote Copper Mine Operations Using IOWN® APN6.8.2026 06:30:00 CEST | Press release
NTT DOCOMO BUSINESS, Inc. (formerly NTT Communications Corporation) has launched a study and proof of concept jointly with Corporación Nacional del Cobre de Chile (CODELCO) to progress remote operations at CODELCO’s copper mines using an IOWN® All-Photonics Network (APN).1 This initiative is part of a research project commissioned by Japan’s Ministry of Internal Affairs and Communications.2 This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260806845222/en/ Conceptual Diagram of the Demonstration To address operational challenges faced by CODELCO’s copper mines, the initiative will connect a copper mine and a remote operations center—approximately 1,500 km apart—via an IOWN APN. It will assess the feasibility of remotely operating heavy machinery using high-capacity, low-latency communication links, enhancing monitoring operations through high-definition video, and implementing a remote operations model. 1. Background Chile is o
FPT Named an OpenAI Select Partner6.8.2026 02:00:00 CEST | Press release
Global IT corporation FPT today announced that it has been named an OpenAI Select Partner within the OpenAI Partner Network. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260805503787/en/ FPT Named an OpenAI Select Partner The OpenAI Partner Network is a global program for partners to build, sell, and deliver AI solutions with OpenAI. It brings together partners with deep industry expertise, delivery capabilities, and customer relationships while equipping them with resources, enablement, and support to help enterprises adopt OpenAI frontier models and products and turn them into measurable impact. As an OpenAI Select Partner, FPT will continue working with OpenAI to help organizations build, deploy, and scale AI solutions responsibly and effectively. This work will help organizations get more useful work from every token and stronger performance per dollar with GPT‑5.6, while using ChatGPT Work to turn ambitious goals into
U.S. FDA Approves Takeda’s ORZEYFUL™ (oveporexton), the First and Only Medicine to Treat the Underlying Cause of Narcolepsy Type 16.8.2026 00:10:00 CEST | Press release
Adults Taking ORZEYFUL Experienced Significant and Meaningful Improvements Across the Full Range of Symptoms of Narcolepsy Type 1 (NT1) in Clinical Trials Compared to Those on Placebo As a First-in-Class Orexin Treatment, ORZEYFUL has the Potential to Redefine NT1 Care Beyond Individual Symptoms Takeda is Advancing U.S. Launch Preparations and Expects to Make ORZEYFUL Available Following Completion of the Drug Enforcement Administration (DEA) Scheduling Process Takeda (TSE:4502/NYSE:TAK) announced that the U.S. Food and Drug Administration (FDA) approved ORZEYFUL™ (oveporexton), an oral orexin receptor 2 (OX2R) agonist, for the treatment of narcolepsy type 1 (NT1, narcolepsy with cataplexy) in adults.* The persistent 24-hour nature of NT1 is driven by orexin deficiency and can severely impact people’s lives. As a first-in-class orexin treatment, ORZEYFUL is the only medicine indicated in the U.S. to treat the disease holistically rather than individual symptoms. “The FDA approval of OR
Compass Pathways Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)5.8.2026 22:30:00 CEST | Press release
Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to unlocking urgently needed new treatment options in mental health care, announced today that Compass granted equity awards under the Compass Pathways plc 2026 Inducement Plan to fourteen newly hired non-executive employees. The equity awards were granted on August 3, 2026 and consisted of options to purchase an aggregate of 139,355 shares and restricted share units or, in the case of employees in the United Kingdom nominal cost options, covering an aggregate of 66,300 shares. The options have an exercise price per share equal to $11.25, the closing price of the Company’s American Depositary Shares on the Nasdaq Global Select Market on the grant date, and will vest over a four-year period with 25% vesting on the first anniversary of the date of the grant and the remaining 75% vesting in equal monthly installments over the three-year period thereafter, subject to each employee’s continued employment. The restricted
Clinilabs Announces Medical Leadership Appointments5.8.2026 16:05:00 CEST | Press release
Bob Dagher, M.D., Named Chief Medical Officer and Waqar Ahmed Siddiqui, M.D., Named Principal Investigator Clinilabs (“Clinilabs LLC”), a global, full-service contract research organization (CRO) specializing in central nervous system (CNS) drug and device development, today announced the appointments of Bob Dagher, M.D., as Chief Medical Officer and Waqar Ahmed Siddiqui, M.D., as Principal Investigator of the Company’s Eatontown, New Jersey Clinical Research Unit (CRU). Dr. Dagher will provide strategic and medical leadership across the organization, while Dr. Siddiqui will lead the execution of research projects at the Company’s CRU. Together, they will support the design, development, and execution of clinical programs for pharmaceutical, biotechnology, and medical device sponsors advancing innovative therapies for psychiatric, neurological, substance use, and rare CNS disorders. “Clinilabs has earned the trust of sponsors by combining deep scientific expertise, medical leadership,
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
